Abstract
Histiocytic disorders of the lung cover a wide range of conditions that can involve the lung in isolation or as part of a systemic process. These diseases are caused by proliferative abnormalities of cells of the mononuclear phagocyte system and their principal cell, the histiocyte. Histiocytes comprise a group of immune cells, including antigen-processing macrophages and antigen-presenting dendritic cells (Favara et al., Med Pediatr Oncol 29:157-166, 1997; McClain et al., Hematology Am Soc Hematol Educ Program 283-296, 2004; Wang et al., Semin Diagn Pathol 24: 162-182, 2007). Histiocytic disorders, both benign and malignant, are relatively rare in the bronchopulmonary system and can cause a spectrum of conditions with clinical behavior ranging from spontaneous regression to life-threatening syndromes. Some of these disorders present as primary lesions and are of unknown etiology, while others are the result of a histiocytic response to a known cause.
Original language | English (US) |
---|---|
Title of host publication | Diagnostic Thoracic Pathology |
Publisher | Springer International Publishing |
Pages | 209-233 |
Number of pages | 25 |
ISBN (Electronic) | 9783030364380 |
ISBN (Print) | 9783030364373 |
DOIs | |
State | Published - Jan 1 2020 |
Keywords
- Crystal-storing histiocytosis
- Erdheim-Chester disease
- Histiocytic disorders of lung
- Langerhans cell histiocytosis
- proliferations
- Pulmonary
- Pulmonary malakoplakia
- Pulmonary storage diseases
- Pulmonary xanthomatous
- Rosai-Dorfman disease
- Whipple disease
ASJC Scopus subject areas
- General Medicine